Mosquitoes are becoming more resistant to current pesticides. That's troubling to Kansas State University biologist Kristin Michel, as it means malaria and other mosquito-borne diseases will continue spreading. A recent grant from the National Institutes of Health may change all that.
Michel, an assistant professor of biology, is using the nearly $1.5 million grant for the four-year study, "The function(s) of serpin-2 in mosquito immunity and physiology." Findings from this investigation into the role of the serpin-2 molecule in Anopheles gambiae -- the African malaria mosquito -- could stop the transmission of malaria and other mosquito-spread diseases by making mosquitoes susceptible to the very diseases they transmit.
As principal investigator, Michel and her laboratory team are focusing on definitively understanding the role of serpin-2 in the mosquito's body. Serpins are a group of similarly structured proteins that can inhibit a group of enzymes that break down proteins called proteases. Serpin-2 controls certain proteases that create immunity against bacteria and fungi in the mosquito.
"Current insecticides used for controlling vector-borne diseases are chemicals that target an insect's nervous system," Michel says. "Because serpin-2 relates to a mosquito's immunity, it could act as a novel insecticide target." Attacking this molecule could avoid or disrupt a response from the mosquito's immune system that would otherwise protect the insect, she adds.
The idea for the research came from a previous project conducted by Michel and fellow Kansas State researchers. By removing serpin-2 from the mosquitoes' bodies, the researchers noticed melanization is affected. In insects melanin is used to encompass foreign objects that enter their body, like bacteria and parasites. This process prevents the insect's immune system from constantly fighting the foreign body. It also causes pseudo-tumors in the mosquitoes once serpin-2 is removed.
"We don't really quite understand yet why this happens, but we do know that the mosquito's immune response is totally overamplified," Michel says. "Instead of melanizing parasites or bacteria, the mosquito's body attacks itself, getting melanotic pseudo-tumors throughout it."
These pseudo-tumors appear as black dots on the insect's thorax and abdomen. Afflicted mosquitoes that do not initially die from the tumors steadily lose interest in blood feeding over time.
"So what we're going to do with this grant is to find out which proteases -- since it's most likely more than one -- are being inhibited by serpin-2 for this whole process to occur," Michel says. "Right now we have very little information about the cloud of proteases that float around in the insect, with regards to what they do and how they interact."
Finding the proteases will require lots of detective work as more than 50 proteases are potentially being inhibited by serpin-2. However, Michel said, the most time-consuming portion may be collecting enough material from the mosquitoes to sample, as one mosquito yields about 0.1 microliters of bodily material.
Several co-investigators are also lending their expertise to the study. Michael Kanost, university distinguished professor and head of the department of biochemistry, is helping with expression of proteases and in vitro testing. Christopher Culbertson, associate professor of chemistry, is building microfluidics technology that will allow for better plasma analysis from the mosquitoes, potentially helping with the sample sizes. Scott Lovell, director of the protein structure laboratory at the University of Kansas, will use X-ray crystallography to visualize how serpin-2 binds to the proteases it inhibits.
"By the end of the study we really hope to say serpin-2 is a perfect target for an insecticide that prevents the mosquito's immunity," Michel says. "The next step will be then to find such chemicals. That's where we're hoping to take this research."
Dear Helpdesk: Working in a Toxic Health Care Environment
March 28th 2024Dear Helpdesk is your steadfast companion, offering life coaching and workplace advice from 2 seasoned IPs for some of your most challenging real-life situations. Let us help you navigate the intersection between work and life, guiding you to navigate the dynamic world of infection prevention with confidence and grace. This article is on handling a toxic health care environment.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.